A novel NFAT inhibitory peptide (RCAN-11R) provides immunosuppression.
Project/Area Number |
26670590
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
General surgery
|
Research Institution | University of the Ryukyus |
Principal Investigator |
NOGUCHI Hirofumi 琉球大学, 医学(系)研究科(研究院), 教授 (50378733)
|
Project Period (FY) |
2014-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 免疫抑制剤 / 副作用 / 糖尿病 / 膵島移植 / 細胞毒性 / RCAN蛋白 / 蛋白導入法 / カルシニューリンインヒビター |
Outline of Final Research Achievements |
Calcineurin inhibitors have been used for the transplant therapy. However, the inhibition of calcineurin outside the immune system has a number of side effects such as diabetes. We previously developed a cell-permeable inhibitor of NFAT (nuclear factor of activated T cells). This peptide (11R-VIVIT) did not affect insulin secretion. However, our recent study showed that 11R-VIVIT affected cell viability when used higher concentration because of VIVIT sequence. The aim of this study is to develop another safer NFAT inhibitor (RCAN-11R) without cell viability less toxic than calcineurin inhibitors. The peptide could interfere selectively with calcineurin-NFAT interaction without affecting calcineurin phosphatase activity similar to 11R-VIVIT. RCAN-11R did not affected cell viability when used as same concentration as toxic concentration of 11R-VIVIT. Therefore, RCAN-11R could be useful as a therapeutic agent that is less toxic than current drugs or 11R-VIVIT.
|
Report
(3 results)
Research Products
(11 results)
-
-
-
[Journal Article] Choice of feeders is important when first establishing iPSCs derived from primarily cultured human deciduous tooth dental pulp cells.2015
Author(s)
Saitoh I, Inada E, Iwase Y, Noguchi H, Murakami T, Soda M, Kubota N, Hasegawa H, Akasaka E, Matsumoto Y, Oka K, Yamasaki Y, Hayasaki H, Sato M
-
Journal Title
Cell Medicine
Volume: 8
Issue: 1-2
Pages: 9-23
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
[Journal Article] A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1.2014
Author(s)
Shimoda M, Chen S, Noguchi H, Takita M, Sugimoto K, Itoh T, Chujo D, Iwahashi S, Naziruddin B, Levy MF, Matsumoto S, Grayburn PA.
-
Journal Title
Hum Gene Ther Methods.
Volume: 25
Issue: 3
Pages: 206-219
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Novel positively charged nanoparticle labeling for in vivo imaging of adipose tissue-derived stem cells.2014
Author(s)
Yukawa H, Nakagawa S, Yoshizumi Y, Watanabe M, Saito H, Miyamoto Y, Noguchi H, Oishi K, Ono K, Sawada M, Kato I, Onoshima D, Obayashi M, Hayashi Y, Kaji N, Ishikawa T, Hayashi S, Baba Y.
-
Journal Title
PLoS One.
Volume: 9
Issue: 11
Pages: e110142-e110142
DOI
Related Report
Peer Reviewed / Open Access